Many SLC2A1 targeting miRNAs are downregulated in cancer cells, such as miR-148b in gastric cancer, miR-218 in bladder cancer, and miR-328 in colon cancer (Ding et al., 2017; Li et al., 2017; Santasusagna et al., 2018). This evidence concerns the gene SLC2A1 and cancer.